Table 1

Sample description by patient group
Total Placebo Chromium t-test or χ2
N=31 N=15 (48.4%) N=16 (51.6%) p-value
Patient Characteristics
Age (yrs) 37.23 (10.97) 38.60 (10.58) 35.94 (11.53) .51
Gender .87
Male 17 (54.8%) 8 (53.5%) 9 (56.3%) --
Female 14 (45.2%) 7 (46.7%) 7 (43.8%) --
Ethnicity .15
Non-Hispanic white 18 (58.1%) 7 (46.7%) 11 (68.8%) --
African American 6 (19.4%) 4 (26.7%) 2 (12.5%) --
Asian 5 (16.1%) 4 (26.7%) 1 (6.3%) --
Hispanic 2 (6.5%) 0 (0%) 2 (12.5%) --
BMI 23.12 (3.09) 22.68 (2.26) 22.53 (3.74) .45
Waist circumference (cm) 79.54 (13.05) 78.7 (6.93) 80.27 (17.15) .75
Fasting Glucose (mmol/L) 4.81 (0.29) 4.40 (0.27) 4.55 (0.29) .14
Total cholesterol (mmol/L) 4.49 (0.13) 4.41 (0.86) 4.56 (0.82) .61
Triglycerides (mmol/L) 0.91 (0.40) 0.82 (0.17) 1.01 (0.53) .21
LDL cholesterol (mmol/L) 2.25 (0.55) 2.15 (0.45) 2.34 (0.63) .35
HDL cholesterol (mmol/L) 1.51 (0.40) 1.6 (0.44) 1.43 (0.35) .24

Masharani et al.

Masharani et al. BMC Endocrine Disorders 2012 12:31   doi:10.1186/1472-6823-12-31

Open Data